Results 131 to 140 of about 46,300 (164)

SGLT-2 Inhibitors and GLP-1 Receptor Agonists as Combination Therapy in Type 2 Diabetes. [PDF]

Curr Diab Rep
Liakos A, Karagiannis T, Avgerinos I, Bekiari E.   +3 more
europepmc   +1 more source

Cardiovascular benefits of GLP-1 receptor agonists in nonobese patients with HFpEF. [PDF]

Ann Med Surg (Lond)
Haider E, Ahmad N, Khan S, Imran SB.
europepmc   +1 more source

Role of GLP-1 Receptor Agonists in Managing Cancer Therapy-Related Cardiac Dysfunction. [PDF]

J Am Heart Assoc
Vignarajah A, Kim S, Albliwi M, Ahn HM, Izda A, Naffa F, Vigneswaramoorthy N, Barot S, Shah G.   +8 more
europepmc   +1 more source

Genetic evidence for a causal protective effect of GLP-1 receptor agonists on paralytic ileus but not on other gastrointestinal events. [PDF]

Medicine (Baltimore)
Yuan B, Yang Z, Wang C, Zong G, Qiu J, Feng C, Geng X.   +6 more
europepmc   +1 more source

The use of GLP-1 receptor agonists and subsequent risk of nicotine-related events: a cross- sectional study. [PDF]

BMC Public Health
Alsaleh NA, Alsharif AA, Joharji H, Almazyad FA, Alsaidy F, Alsahli M, Aljanadi Q, Babalghaith R, Alfawaz S, Alzahrani N.   +9 more
europepmc   +1 more source

Effects of GLP-1 Receptor Agonists vs Metformin in Polycystic Ovary Syndrome: A Systematic Review and Meta-Analysis. [PDF]

Cureus
Almubaddil K, Alotaibi M, Bin Mutreb L, Alanazi F, Altulihee M.   +4 more
europepmc   +1 more source

GLP-1 Receptor Agonists and Cancer Risk in Adults With Obesity. [PDF]

JAMA Oncol
Dai H, Li Y, Lee YA, Lu Y, George TJ, Donahoo WT, Lee KP, Nakshatri H, Allen J, Guo Y, Sun RC, Guo J, Bian J.   +12 more
europepmc   +1 more source